Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development

Cites (345)

Items 201–345 of 345

1. Growth of β-Amyloid(1−40) Protofibrils by Monomer Elongation and Lateral Association. Characterization of Distinct Products by Light Scattering and Atomic Force Microscopy
   Michael R. Nichols, Melissa A. Moss, Dana Kim Reed, Wen-Lang Lin, Rajendrani Mukhopadhyay, Jan H. Hoh, Terrone L. Rosenberry · 2002 · Biochemistry
2. In-situ atomic force microscopy study of β-amyloid fibrillization
   H.K.L. Blackley, Giles H.W. Sanders, Martyn C. Davies, Clive J. Roberts, Saul J. B. Tendler, M.J Wilkinson · 2000 · Journal of Molecular Biology
3. Tau Proteins and Neurofibrillary Degeneration
   Goedert, M., Spillantini, M. G., Crowther, R. A. · 1991 · Brain Pathology
4. Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid ProductionIn Vivo
   Mark P. Burns, Kate Gaynor, Vicki Olm, Marc H. Mercken, John J. LaFrancois, Lili Wang, Paul M. Mathews, Wendy J. Noble, Yasuji Matsuoka, Karen Duff · 2003 · Journal of Neuroscience
5. A Comparison of Three Fluorophores for the Detection of Amyloid Fibers and Prefibrillar Oligomeric Assemblies. ThT (Thioflavin T); ANS (1-Anilinonaphthalene-8-sulfonic Acid); and bisANS (4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid).
   Nadine D. Younan, J. H. Viles · 2015 · Biochemistry
6. Aβ amyloid fibrils possess a core structure highly resistant to hydrogen exchange
   Indu Kheterpal, Shaolian Zhou, Kelsey D. Cook, Ronald B. Wetzel · 2000 · Proceedings of the National Academy of Sciences
7. The γ-secretase complex: machinery for intramembrane proteolysis
   Takeshi Iwatsubo · 2004 · Current Opinion in Neurobiology
8. Methods for Staining Amyloid in Tissues: A Review
   M. Tarek Elghetany, Abdus Saleem · 1988 · Stain Technology
9. Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease
   Richard C. Dodel, Harald Juergen Hampel, Candan Depboylu, Suizhen Lin, Feng Gao, Sabine Schock, Steffi Jäckel, Xing Wei, Katharina Büerger, Christine Höft et al. · 2002 · Annals of Neurology
10. Specific spatial learning deficits become severe with age in β-amyloid precursor protein transgenic mice that harbor diffuse β-amyloid deposits but do not form plaques
    Milla Koistinaho, Michael Ort, José Manuel Cimadevilla, Roman Vondrous, Barbara Cordell, Jari Koıstınaho, Jan Bureš, Linda Slanec Higgins · 2001 · Proceedings of the National Academy of Sciences
11. Amyloid‐ß‐directed immunotherapy for Alzheimer's disease
    Lars Lannfelt, Norman R. Relkin, Eric Siemers · 2014 · Journal of Internal Medicine
12. Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
    Fabiola Mara Ribeiro, Maryse Paquet, Sean P. Cregan · 2010 · CNS & Neurological Disorders - Drug Targets
13. L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease
    Anekonda, Thimmappa S., Quinn, Joseph F., Harris, Christopher, Frahler, Kate, Wadsworth, Teri L., Woltjer, Randall L. · 2011 · Neurobiology of Disease
14. Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling
    Sajith A. Jayasinghe, Ralf Langen · 2004 · Journal of Biological Chemistry
15. Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory Cytokines
    Giovanni Perini, Vittorina Della Bianca, Valeria Politi, Giuliano Della Valle, Ilaria Dal Prà, Filippo Rossi, Ubaldo Armato · 2002 · The Journal of Experimental Medicine
16. Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β
    Martel, Cynthia L., Mackic, Jasmina B., Matsubara, Etsuro, Governale, Samuel, Miguel, Calero, Miao, Wesley, McComb, J. Gordon, Frangione, Blas, Ghiso, Jorge, Zlokovic, Berislav V. · 1997 · Journal of Neurochemistry
17. Solution Structure of Residues 1-28 of the Amyloid .beta.-Peptide
    Joseph Talafous, Keith J. Marcinowski, Gilles Klopman, Michael G. Zagorski · 1994 · Biochemistry
18. Spectroscopic characterization of diverse amyloid fibrils in vitro by the fluorescent dyeNile red
    Rajesh Mishra, Daniel Sjölander, Per Hammarström · 2011 · Molecular BioSystems
19. ole of apoE/Aβ Interactions in the Pathogenesis of Alzheimer's Disease and Cerebral Amyloid Angiopathy
    Holtzman, David M. · 2001 · Journal of Molecular Neuroscience
20. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
    Luise Christine Löwe, Christian Gaser, Katja Franke, Alzheimer’s Disease Neuroimaging Initiative · 2016 · PLoS ONE
21. Autism, Alzheimer disease, and fragile X
    Sokol, D.K., Maloney, B., Long, J.M., Ray, B., Lahiri, D.K. · 2011 · Neurology
22. BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo
    Lee, Edward B., Zhang, Bin, Liu, Kangning, Greenbaum, Eric A., Doms, Robert W., Trojanowski, John Q., Lee, Virginia M.-Y. · 2005 · The Journal of Cell Biology
23. Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier
    Berislav V. Zloković · 1996 · Life Sciences
24. Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
    Aaron H. Burstein, Imogene Grimes, Douglas R Galasko, Paul S. S Aisen, Marwan Noel Sabbagh, Adnan M.M. Mjalli · 2014 · BMC Neurology
25. Solution Structure of Amyloid β-Peptide (25−35) in Different Media
    Anna Maria D’Ursi, Maria Rosaria Armenante, Remo Guerrini · 2004 · Journal of Medicinal Chemistry
26. Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A
    Alex E. Roher, T.C. Kasunic, Amina S. Woods, Robert J. Cotter, Melvyn J. Ball, Rafael A. Fridman · 1994 · Biochemical and Biophysical Research Communications
27. Genetics of Alzheimer's disease: recent advances
    Avramopoulos, Dimitrios · 2009 · Genome Medicine
28. Characterization of Intermediate Steps in Amyloid Beta (Aβ) Production under Near-native Conditions
    Fredrik Olsson, Staffan Schmidt, Veit Althoff, Lisa Marie Munter, Shaobo Jin, Susanne Rosqvist, Urban Lendahl, Gerd Multhaup, Johan Lundkvist · 2013 · Journal of Biological Chemistry
29. Donepezil
    Harriet M. Bryson, Paul Benfield · 1997 · Drugs & Aging
30. Brain Uptake of Circulating Apolipoproteins J and E Complexed to Alzheimer′s Amyloid β
    Berislav V. Zloković, C.L. Martel, Jasmina B. Mačkić, E. Matsubara, Thomas Wısnıewskı, J. Gordon McComb, Blas Frangione, Jorge A. Ghiso · 1994 · Biochemical and Biophysical Research Communications
31. AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
    Susanna Eketjäll, Juliette Janson, Karin Kaspersson, Anna Bogstedt, Fredrik Jeppsson, Johanna M. Fälting, Samantha Budd Haeberlein, Alan R. Kugler, Robert C. Alexander, Gvido Cebers · 2016 · Journal of Alzheimer s Disease
32. FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer’s disease
    Kam, Tae-In, Song, Sungmin, Gwon, Youngdae, Park, Hyejin, Yan, Ji-Jing, Im, Isak, Choi, Ji-Woo, Choi, Tae-Yong, Kim, Jeongyeon, Song, Dong-Keun et al. · 2013 · Journal of Clinical Investigation
33. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
    Liqin Qi, Linfang Ke, Xiaohong Liu, Lianming Liao, Sujie Ke, Xiaoying Liu, Yanping Wang, Xiaowei Lin, Yu Zhou, Lijuan Wu et al. · 2016 · European Journal of Pharmacology
34. PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease
    Hiroshi Toyama, Daniel G. Ye, Masanori Ichise, Jeih‐San Liow, Lisheng Cai, David M. Jacobowitz, John L. Musachio, Jinsoo S. Hong, Mathew Crescenzo, Dnyanesh N. Tipre et al. · 2005 · European Journal of Nuclear Medicine and Molecular Imaging
35. Alzheimer’s β-peptide oligomer formation at physiologic concentrations
    Harry LeVine · 2004 · Analytical Biochemistry
36. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminili γ1 chain
    Flavio H. Heraldo, C Arantes, Tiago G. Santos, Cleiton F. Machado, Martín Roffé, Glaucia N. Haji, Kil Sun Lee, Ana C. Magalhães, Fabiana A. Caetano, Gabriel. L Mancini et al. · 2010 · The FASEB Journal
37. Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease
    Marzolo, Maria-Paz, Bu, Guojun · 2009 · Seminars in Cell & Developmental Biology
38. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
    Liraz, Ori, Boehm-Cagan, Anat, Michaelson, Daniel M · 2013 · Molecular Neurodegeneration
39. The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
    Puzzo, D., Gulisano, W., Arancio, O., Palmeri, A. · 2015 · Neuroscience
40. Constraints on Supramolecular Structure in Amyloid Fibrils from Two-Dimensional Solid-State NMR Spectroscopy with Uniform Isotopic Labeling
    Robert Tycko, Yoshitaka Ishii · 2003 · Journal of the American Chemical Society
41. Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity
    Juan Carlos Díaz, Olga Šimáková, Kenneth A. Jacobson, Nelson J. Arispe, Harvey B. Pollard · 2009 · Proceedings of the National Academy of Sciences
42. Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid‐β Neurotoxicity and Deposition
    H. Michael Tucker, Muthoni Kihiko‐Ehmann, Sarah Wright, Russell E. Rydel, Steven Estus · 2000 · Journal of Neurochemistry
43. Passage of human amyloid β-protein 1–40 across the murine blood-brain barrier
    Lawrence M. Maness, William A. Banks, Marcia Berman Podlisny, Dennis J. Selkoe, Abba J. Kastin · 1994 · Life Sciences
44. Plasmin Cleavage of the Amyloid β-Protein: Alteration of Secondary Structure and Stimulation of Tissue Plasminogen Activator Activity
    William E. Van Nostrand, Margaret D. Porter · 1999 · Biochemistry
45. Apolipoprotein E, Amyloid, and Alzheimer Disease
    Kelly R. Bales · 2002 · Molecular Interventions
46. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease
    Choi, Bo-Ryoung, Cho, Woo-Hyun, Kim, Jiyoung, Lee, Hyong Joo, Chung, ChiHye, Jeon, Won Kyung, Han, Jung-Soo · 2014 · Experimental & Molecular Medicine
47. Endoplasmic reticulum stress occurs downstream of GluN2B subunit ofN‐methyl‐D‐aspartate receptor in mature hippocampal cultures treated with amyloid‐β oligomers
    Rui O. Costa, Pascale N. Lacor, Ildete L. Ferreira, Rosa Resende, Yves P. Auberson, William L. Klein, Catarina Resende Oliveira, Ana Cristina Rego, Cláudia Pereira · 2012 · Aging Cell
48. A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation
    Angela Fortner McKoy, Jermont Chen, Trudi Schüpbach, Michael H. Hecht · 2012 · Journal of Biological Chemistry
49. Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
    Vincenza Frisardi, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Cristiano A. Capurso, Alessia D’Introno, Anna Maria Colacicco, Gianluigi Vendemiale, Davide Seripa, Alberto Pilotto, Cristiano A. Capurso et al. · 2010 · Current Alzheimer Research
50. Progress in Clinical, Pharmacological, Chemical and Structural Biological Studies of Huperzine A: A Drug of Traditional Chinese Medicine Origin for the Treatment of Alzheimers Disease
    Hualiang Jiang, Xiaomin Luo, Donglu Bai · 2003 · Current Medicinal Chemistry
51. Neurovascular Pathways and Alzheimer Amyloid β-peptide
    Zlokovic, Berislav V., Deane, Rashid, Sallstrom, Jan, Chow, Nienwen, Miano, Joseph M. · 2006 · Brain Pathology
52. Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center
    Deborah D. Soto-Ortega, Brandon P. Murphy, Francisco J. Gonzalez‐Velasquez, Kelly A. Wilson, Fang Xie, Qian Wang, Melissa A. Moss · 2011 · Bioorganic & Medicinal Chemistry
53. Reprint of “Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein”
    George G. Glenner · 2012 · Biochemical and Biophysical Research Communications
54. APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation
    Kaushik Ghosal, Andrea M. Stathopoulos, Sanjay W. Pimplikar · 2010 · PLoS ONE
55. Selective destabilization of soluble amyloid β oligomers by divalent metal ions
    Garai, K., Sengupta, P., Sahoo, B., Maiti, S. · 2006 · Biochemical and Biophysical Research Communications
56. Biochemical Identification of the Neutral Endopeptidase Family Member Responsible for the Catabolism of Amyloid Peptide in the Brain
    Y. Takaki, Nobuhisa Iwata, Satoshi Tsubuki, S. Taniguchi, S. Toyoshima, B. Lu, Norma P. Gerard, Craig J Gerard, How‐Jing Lee, Keiro Shirotani et al. · 2000 · The Journal of Biochemistry
57. LRP-1: A Checkpoint for the Extracellular Matrix Proteolysis
    Nicolas Etique, Laurie Verzeaux, Stéphane Dedieu, Hervé Emonard · 2013 · BioMed Research International
58. A glucan isolated from flowers of Lonicera japonica Thunb. inhibits aggregation and neurotoxicity of Aβ42
    Wang, Peipei, Liao, Wenfeng, Fang, Jianping, Liu, Qin, Yao, Jian, Hu, Minghua, Ding, Kan · 2014 · Carbohydrate Polymers
59. Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E
    Servet M. Yatin, Mustafa Yatin, Timothy Aulick, Kenneth B. Ain, David Allan Butterfield · 1999 · Neuroscience Letters
60. Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies
    Gabriela A. N. Crespi, Stefan J. Hermans, Michael W. Parker, Luke A. Miles · 2015 · Scientific Reports
61. GM1 Ganglioside Inhibits β‐Amyloid Oligomerization Induced by Sphingomyelin
    Mariana Amaro, Radek Šachl, Gokcan Aydogan, Ilya I. Mikhalyov, Robert Vácha, Martin Hof · 2016 · Angewandte Chemie International Edition
62. Golgi defects enhance APP amyloidogenic processing in Alzheimer's disease
    Gunjan S. Joshi, Yanzhuang Wang · 2014 · BioEssays
63. Capping of Aβ42 Oligomers by Small Molecule Inhibitors
    Ziao Fu, Darryl Aucoin, Mahiuddin Ahmed, Martine Ziliox, William E. Van Nostrand, Steven O. Smith · 2014 · Biochemistry
64. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques
    Kumi Sato, Makoto Higuchi, Nobuhisa Iwata, Takaomi C. Saido, Kazumi Sasamoto · 2004 · European Journal of Medicinal Chemistry
65. Alzheimer’s disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio
    Ting-Hai Xu, Yan Yan, Yanyong Kang, Yi Jiang, Karsten Melcher, H. Eric Xu · 2016 · Cell Discovery
66. Identification of a β-Secretase Activity, Which Truncates Amyloid β-Peptide after Its Presenilin-dependent Generation
    Regina Fluhrer, Gerd Multhaup, Andrea Schlicksupp, Masayasu Okochi, Masatoshi Takeda, Sven Lammich, Michael Willem, Gil G. Westmeyer, Wolfram Bode, Jochen Walter et al. · 2003 · Journal of Biological Chemistry
67. Potential Therapeutic Strategies for Alzheimer’s Disease Targeting or Beyondβ-Amyloid: Insights from Clinical Trials
    Qiutian Jia, Yulin Deng, Hong Qing · 2014 · BioMed Research International
68. Ten Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
    Kasper P. Kepp · 2016 · Journal of Alzheimer s Disease
69. Neprilysin-2 Is an Important β-Amyloid Degrading Enzyme
    Daniel M. Hafez, Jeffrey Y. Huang, Alexis M. Huynh, Stephanie Valtierra, Edward M. Rockenstein, Angela M. Bruno, Bao Lu, Luc DesGroseillers, Eliezer Masliah, Robert A. Marr · 2011 · American Journal Of Pathology
70. Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches
    Claudio A. Soto · 1999 · Journal of Molecular Medicine
71. Effects of 5‐HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat
    B Marcos, Tsu Tshen Chuang, Francisco Javier Gil-Bea · 2008 · British Journal of Pharmacology
72. Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization
    Wei Zhao, Jun Wang, Lap Ho, Kenjiro Ono, David B. Teplow, Giulio Maria Pasinetti · 2009 · Journal of Alzheimer s Disease
73. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer’s disease mice
    Panchanan Maiti, Tia C. Hall, Leela Paladugu, Nivya Kolli, Cameron R. Learman, Julien Rossignol, Gary Leo Dunbar · 2016 · Histochemistry and Cell Biology
74. 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer’s disease
    Nancy A. Dezutter, R. Dom, T. de Groot, G. Bormans, A. Verbruggen · 1999 · European Journal of Nuclear Medicine
75. An activity‐dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors
    Valeria Bruno, Giuseppe Battaglia, Agata Copani, Virtudes M. Cespédes, María Francisca Galindo, Valentı́n Ceña, José Sánchez‐Prieto, Fabrizio Gasparini, Rainer R. Kuhn, Peter Josef Flor et al. · 2001 · European Journal of Neuroscience
76. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor
    Philippe Naveilhan, Isabelle Neveu, Christel Baudet, Hiroshi Funakoshi, Didier Wion, Philippe Brachet, Madis L. METSIS · 1996 · Molecular Brain Research
77. 2,2′,4′‐Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice
    Zhiyuan Zhu, Chenjing Li, Xu Wang, Zhengyi Yang, Jing Chen, Lihong Hu, Hualiang Jiang, Xu Shen · 2010 · Journal of Neurochemistry
78. Inhibition of Alzheimer's β-Amyloid Induced Vasoactivity and Proinflammatory Response in Microglia by a cGMP-Dependent Mechanism
    Daniel Paris, Terrence Town, Timothy A. Parker, Jun Tan, James Humphrey, Fiona Crawford, MICHAEL J. MULLAN · 1999 · Experimental Neurology
79. Degradation of Alzheimerʼs β-amyloid protein by human cathepsin D
    JOHN R. MCDERMOTT, ALISON M. GIBSON · 1996 · Neuroreport
80. Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives
    Nikolaos K. R K Robakis · 2010 · Neurobiology of Aging
81. Fluorometric Examination of Tissue Amyloid Fibrils in Murine Senile Amyloidosis: Use of the Fluorescent Indicator, Thioflavine T
    Hironobu Naiki, Keiichi Higuchi, Kaori Kitagawa · 1991 · Springer eBooks
82. Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer’s Amyloid β‐Peptide Aggregation
    Tahiri Sylla, Laurent Pouységu, Grégory Da Costa, Denis Deffieux, Jean‐Pierre Monti, Stéphane Quideau · 2015 · Angewandte Chemie International Edition
83. Bexarotene Blocks Calcium-Permeable Ion Channels Formed by Neurotoxic Alzheimer’s β-Amyloid Peptides
    Jacques Fantini, Coralie Di Scala, Nouara Yahi, Jean‐Denis Troadec, Kevin Sadelli, Henri Chahinian, Nicolas Garmy · 2014 · ACS Chemical Neuroscience
84. The Migration of Human Smooth Muscle Cells In Vitro Is Mediated by Plasminogen Activation and Can Be Inhibited by α2-Macroglobulin Receptor Associated Protein
    M.J. Wijnberg, Paul H.A. Quax, Nancy M. E. NIEUWENBROEK · 1997 · Thrombosis and Haemostasis
85. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease
    Z.X. Shen · 2004 · Medical Hypotheses
86. Identification of BACE2 as an avid ß-amyloid-degrading protease
    Samer O. Abdul‐Hay, Tomoko Sahara, Melinda McBride, Dongcheul Kang, Malcolm A. Leissring · 2012 · Molecular Neurodegeneration
87. Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
    Rina Yamin, Cheng Zhao, Peter B. O’Connor, Ann Carolyn McKee, Carmela R. Abraham · 2009 · Molecular Neurodegeneration
88. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid‐β peptides via p75NTR/PLAIDD
    Yuichi Hashimoto, Yuka Kaneko, Emi Tsukamoto, Harald Frankowski, Keisuke Kouyama, Yoshiko A. Kita, Takako Niikura, Sadakazu Aiso, Dale E. Bredesen, Masaaki Matsuoka et al. · 2004 · Journal of Neurochemistry
89. The Chemerin Receptor CMKLR1 is a Functional Receptor for Amyloid-β Peptide
    Peng Lei, Yang Yu, Jin Liu, Shuqin Li, Huiqiong He, Ni Cheng, Richard D. Ye · 2014 · Journal of Alzheimer s Disease
90. Method for measurement of the blood–brain barrier permeability in the perfused mouse brain: application to amyloid-β peptide in wild type and Alzheimer’s Tg2576 mice
    Barbra LaRue, Elizabeth Hogg, Abhay P. Sagare, Suzana S. Jovanovic, Lawrence M. Maness, Calvin R. Maurer, Rashid Deane, Berislav V. Zloković · 2004 · Journal of Neuroscience Methods
91. Novel Anti-Alzheimer's Dimer Bis(7)-Cognitin: Cellular and Molecular Mechanisms of Neuroprotection Through Multiple Targets
    Wenming Li, Shinghung Mak, Hualiang Jiang, Qinwen Wang, Yuan‐Ping Pang, Kaixian Chen, Yifan Han · 2008 · Neurotherapeutics
92. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
    Shankaramma Shivaprasad, R. Wetzel · 2004 · Biochemistry
93. Insulin Acts Intracellularly on Proteasomes through Insulin-Degrading Enzyme
    William C. Duckworth, Robert G. Bennett, Frederick G. Hamel · 1998 · Biochemical and Biophysical Research Communications
94. Physiological and pathological roles of the γ-secretase complex
    Courtney M. Carroll, Yue‐Ming Li · 2016 · Brain Research Bulletin
95. Generic inhibition of amyloidogenic proteins by two naphthoquinone–tryptophan hybrid molecules
    Roni Scherzer‐Attali, Ronit Shaltiel‐Karyo, Yonatan H. Adalist, Daniel Segal, Ehud Gazit · 2012 · Proteins Structure Function and Bioinformatics
96. Human Plasma Contains Cross-Reactive Aβ Conformer-Specific IgG Antibodies
    Brian O’Nuallain, Luis F. Acero, Angela D. Williams, Helen P. McWilliams‐Koeppen, Alfred Weber, Hans Peter Schwarz, Jonathan S. Wall, Deborah T. Weiss, Alan Solomon · 2008 · Biochemistry
97. Association of apolipoprotein ?4 allele and neuropathologic findings in patients with dementia
    Maria‐Grazia Martinoli, John Q. Trojanowski, M. L. Schmidt, Steven Edward Arnold, Takuya Fujiwara, V. M. -Y. Lee, Howard I. Hurtig, Jean‐Pierre Julien, Cecilia N. Clark · 1995 · Acta Neuropathologica
98. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
    Anna Chiarini, Ilaria Dal Prà, Whitfield Jf, Ubaldo Armato · 2006 · PubMed
99. Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity
    Sohini Chakrabortee, Yun Liu, Liao Zhang, Helena R. Matthews, Hanrui Zhang, Ni Pan, Chun‐Ru Cheng, Shuhong Guan, De‐an Guo, Zebo Huang et al. · 2011 · Biochemical Journal
100. Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N 2a cells
     Yimin Tao, Li Fang, Yiming Yang, Hualiang Jiang, Huaiyu Yang, Haiyan Zhang, Hu Zhou · 2013 · PROTEOMICS
101. Profile of gantenerumab and its potential in the treatment of Alzheimer's disease
     Robert Nisticò, Dijana Novakovic, Marco Feligioni, Sergio Scaccianoce, Sonia Piccinin, Nicola Biagio Mercuri, Ferdinando Nicoletti, Alessandra Caruso, Chiara Schepisi, Francesco Errico · 2013 · Drug Design Development and Therapy
102. NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease
     BRIAN A. LAWLOR, Seán Kennelly, Sarah O'Dwyer, Fiona Cregg, Cathal Walsh, Robert F. Coen, Rose Anne Kenny, Robert J. Howard, Caroline Murphy, Jessica Adams et al. · 2014 · BMJ Open
103. A historical note on the iodine-sulphuric acid reaction of amyloid
     Kurt Aterman · 1976 · Histochemistry and Cell Biology
104. Implication of the small GTPase Rac1 in the generation of reactive oxygen species in response to β-amyloid in C6 astroglioma cells
     Mina Lee, Hye Jin You, Sung-Hoon Cho, Chang-Hoon Woo, Min‐Hyuk Yoo, Eun-hye Joe, Jae‐Hong Kim · 2002 · Biochemical Journal
105. Structure of ring-shaped Aβ42 oligomers determined by conformational selection
     Linh Tran, Nathalie Basdevant, Chantal Prévost, Tâp Ha‐Duong · 2016 · Scientific Reports
106. Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice
     P. Fernández‐Vizarra, Óscar López‐Franco, Beñat Mallavia, Alejandro Higuera‐Matas, Virginia López-Parra, Guadalupe Ortiz-Muñoz, E. Ambrosio, Jesús Egido, Osborne F. X. Almeida, Carmen Gómez‐Guerrero · 2012 · Brain
107. Autosomal‐dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production
     Marc Suárez‐Calvet, Olivia Belbin, Marta Pera, Nahuai Badiola, Jordi Magrané, Cristina Guardia‐Laguarta, Laia Muñoz, Martí Colom‐Cadena, Jordi Clarimón, Alberto Lleó · 2013 · Journal of Neurochemistry
108. Exceptional Amyloid β Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds
     Hiroaki Taguchi, Stephanie A. Planque, Gopal Sapparapu, Stéphane Boivin, Mariko Hara, Yasuhiro Nishiyama, Sudhir Paul · 2008 · Journal of Biological Chemistry
109. Catalytic antibodies to amyloid β peptide in defense against Alzheimer disease
     Hiroaki Taguchi, Stephanie A. Planque, Yasuhiro Nishiyama, Paul Szabo, Marc E. Weksler, Robert Paul Friedland, Sudhir Paul · 2008 · Autoimmunity Reviews
110. Enhancement of β‐Amyloid Peptide Aβ(1–40)‐Mediated Neurotoxicity by Glutamine Synthetase
     Michael Y. Aksenov, Marina V Aksenova, Marni E. Harris‐White, Kenneth Hensley, David Allan Butterfield, John M. Carney · 1995 · Journal of Neurochemistry
111. Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid‐β peptide
     Rina Yamin, Sandipan Bagchi, Rick Hildebrant, Andrea Scaloni, Russell L. Widom, Carmela R. Abraham · 2006 · Journal of Neurochemistry
112. Invited review: Drug development for tauopathies
     Fiona Grüninger · 2014 · Neuropathology and Applied Neurobiology
113. Enhanced correction methods for hydrogen exchange‐mass spectrometric studies of amyloid fibrils
     Indu Kheterpal, Ronald B. Wetzel, Kelsey D. Cook · 2003 · Protein Science
114. Resveratrol: un polifenol neuroprotector de la dieta mediterránea
     Visitación López-Miranda González, María Luisa Soto‐Montenegro, Gema Vera, Esperanza Herradón, Manuel Desco, Raquel Abalo · 2012 · Revista de Neurología
115. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model
     Roni Scherzer‐Attali, Dorit Farfara, Itzik Cooper, Aviad Levin, Tali Benromano, Dorit Trudler, M. Vientrov, Ronit Shaltiel‐Karyo, Deborah E. Shalev, Niva Segev‐Amzaleg et al. · 2012 · Neurobiology of Disease
116. Cdk5: Mediator of neuronal development, death and the response to DNA damage
     Jinqiu Zhu, Wenming Li, Zixu Mao · 2011 · Mechanisms of Ageing and Development
117. Molecule of the Month
     Andrew S. Felts · 2008 · Current Topics in Medicinal Chemistry
118. Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats
     Ivica Granic, Csaba J. Nyakas, Paul G.M. Luiten, Ulrich L.M. Eisel, László G. Halmy, Gerhard Groß, Hans Schoemaker, Achim Möller, Volker Nimmrich · 2010 · Neuropharmacology
119. Preclinical Investigation of the Functional Effects of Memantine and Memantine Combined with Galantamine or Donepezil
     Diana S. Woodruff‐Pak, Michael J. Tobia, Xilu Jiao, Kevin D. Beck, Richard J. Servatius · 2006 · Neuropsychopharmacology
120. Adherence to Antiretroviral Therapy in Managed Care Members in the United States: A Retrospective Claims Analysis
     Catherine E. Cooke, Helen Y. Lee, Shan Xing · 2014 · Journal of Managed Care Pharmacy
121. Influence of LRP-1 and Apolipoprotein E on Amyloid-β Uptake and Toxicity to Cerebrovascular Smooth Muscle Cells
     Wan Adriyani Wan Ruzali, Patrick G. Kehoe, Seth Love · 2012 · Journal of Alzheimer s Disease
122. Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives as β-Amyloid Peptide Aggregation Inhibitors
     Yu Zhou, Chun‐Yi Jiang, Yaping Zhang, Zhongjie T. Liang, Wenfeng Liu, Liefeng Wang, Cheng Luo, Tingting Zhong, Yi Eve Sun, Linxiang Zhao et al. · 2010 · Journal of Medicinal Chemistry
123. Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease
     Matthias W. Riepe, Georg Adler, Bernd Ibach · 2006 · The Primary Care Companion For CNS Disorders
124. Mutation Screening and Association Study of the Neprilysin Gene in Sporadic Alzheimer's Disease in Chinese Persons
     Jiajun Shi, Sizhong Zhang, Mouni Tang et al. · 2005 · The Journals of Gerontology Series A
125. Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40
     Jiayi Huang, A.M. Bruno, C.A. Patel, Alexis M. Huynh, Keith Philibert, M.J. Glucksman, Robert A. Marr · 2008 · Neuroscience
126. Metal-dependent amyloid β-degrading catalytic antibody construct
     Yasuhiro Nishiyama, Hiroaki Taguchi, Mariko Hara, Stephanie A. Planque, Yukie Mitsuda, Sudhir Paul · 2014 · Journal of Biotechnology
127. A tale of two drug targets: the evolutionary history of BACE1 and BACE2
     Christopher Southan, John M. Hancock · 2013 · Frontiers in Genetics
128. Time-Lapse Atomic Force Microscopy in the Characterization of Amyloid-Like Fibril Assembly and Oligomeric Intermediates
     Claire S. Goldsbury, Janelle Green · 2005 · Humana Press eBooks
129. The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease
     Shucai Ling, Jing Zhou, John Anthony Rudd, Zhiying Hu, Marong Fang · 2011 · The Anatomical Record
130. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).
     Robert Angus, Evelyn A. Millar, George W. Chalmers · 1996 · Thorax
131. Protein Interactions Between the C-Terminus of Aβ-Peptide and Phospholipase A2 - A Structure Biology Based Approach to Identify Novel Alzheimer’s Therapeutics
     Zeenat Mirza, Vikram Gopalakrishna Pillai, Mohammad Amjad Kamal · 2014 · CNS & Neurological Disorders - Drug Targets
132. A New Perspective of Lysosomal Cation Channel-Dependent Homeostasis in Alzheimer’s Disease
     Martin Ezeani, Maxwell Omabe · 2015 · Molecular Neurobiology
133. Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie
     Giorgio Poli, Erica Corda, Barbara Lucchini et al. · 2012 · Prion
134. Changes in γ-secretase activity and specificity caused by the introduction of consensus aspartyl protease active motif in Presenilin 1
     Donald B. Carter, Edwige Dunn, Adele M. Pauley, Denise D. McKinley, Timothy J. Fleck, Brenda R. Ellerbrock, Nancy C. Stratman, Xiangdong Zhou, Carol S. Himes, Jeffrey S. Nye et al. · 2008 · Molecular Neurodegeneration
135. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease
     Chiou-Miin Wang, Sarah deVries, Marybeth Camboni, Matthew Glass, Paul T. Martin · 2010 · Neurobiology of Disease
136. Attack on amyloid
     Philipp J. Kahle, Bart De Strooper · 2003 · EMBO Reports
137. Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes.
     1990 · PubMed
138. A drug targeting intracellular amyloid-β and oxidative stress: Apomorphine
     Yasumasa Ohyagi · 2011 · Rinsho Shinkeigaku
139. Potential Savings in the Cost of Caring for Alzheimer??s Disease
     Karen W. Linkins, John R. Lloyd, Gregory O. Hjelmstad · 2000 · PharmacoEconomics
140. IMMUNOCYTOCHEMICAL AND LECTIN HISTOCHEMICAL STUDIES OF PLAQUES AND TANGLES IN DOWN??S SYNDROME PATIENTS OF DIFFERENT AGES
     D.M.A. Mann · 1988 · Alzheimer Disease & Associated Disorders
141. Immunocytochemical and lectin histochemical studies of plaques and tangles in Down's syndrome patients at different ages.
     Mann Dm, A Brown, Wilks Dp · 1989 · PubMed
142. K114 Inhibits A-beta Aggregation and Inflammation In Vitro and In Vivo in AD/Tg Mice
     Yi-Hong Zhang, Dushyant Mann, James B. Raymick · 2014 · Current Alzheimer Research
143. Namzaric--a combination of 2 old drugs for Alzheimer's disease.
     2015 · PubMed
144. Molecule of the month. Semagacestat.
     2008 · PubMed
145. Untitled work
     Kordower · 1999 · 10.1002/1531-8249(199909)46:3